D. E. Shaw & Co., Inc. Zai Lab LTD Put Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$13.72 - $21.55 $507,640 - $797,350	37,000 Added 115.63%	69,000 $1.2 Million
Q1 2024 May 15, 2024	BUY	$15.95 - $26.8 $510,400 - $857,600	32,000 New	32,000 $512,000
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $315,675 - $479,275	2,500 New	2,500 $334,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.